- Over 420 million people around the globe currently have diabetes, with the figure set to rise by 55% over the next 25 years
- Millions of patients required to measure their blood glucose levels daily to accurately determine their insulin dosage amounts
- Nemaura Medical has launched two constant glucose monitoring solutions – the SugarBEAT(R) device as well as the MiBoKo application, which seek to provide users with a convenient, low-cost non-invasive CGM solution
Diabetes affects 34 million people in the United States and upwards of 400 million people globally, with the number of affected individuals expected to rise by approximately 55 percent within the next 25 years (https://ibn.fm/xuZVf). For many individuals, mealtimes have long proved to be an arduous process. Before eating, diabetic patients must often inject themselves with insulin in a time-consuming process that combines estimations of the meal’s carbohydrate content with blood drawing to calculate the proper amount of insulin for the recipient. As such, the advent of non-invasive constant glucose monitoring (“CGM”) has been a largely welcome one for the industry, with the blood glucose monitoring market forecast to expand to an annual value of $27.2 billion by 2026, with a CAGR of 9.6% between 2021-2026 (https://ibn.fm/5jv2C).
“Every day, many patients need to do this complicated procedure at least three times,” stated Hen-Wei Huang, an MIT post-doctorate student carrying out research into…
NOTE TO INVESTORS: The latest news and updates relating to NMRD are available in the company’s newsroom at https://ibn.fm/NMRD
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.